GC Wealth Management RIA, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2011169
Cambridge, MA
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$456,363
-$97,642 QoQ
Shares Held
1,022
-16.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GC Wealth Management RIA, LLC holds $5,541,194 across 7 Biotechnology names. VRTX ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,297 | $1,774,754 | |
| 2 | CUE |
Cue Biopharma, Inc.
|
4,631,644 | $1,065,278 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
23,999 | $965,479 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
20,027 | $670,503 | |
| 5 | TECH |
BIO-TECHNE Corp
|
11,084 | $579,249 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,022 | $456,363 | |
| 7 | LCTX |
Lineage Cell Therapeutics, Inc.
|
18,714 | $29,568 |
All Filings in VRTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $456,363 | 1,022 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $554,005 | 1,222 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,304,944 | 3,332 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $785,778 | 1,765 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $218,653 | 451 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||